We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 3,511 results
  1. Composition and Pathogenic Potential of Mucosal Microbiota in Ulcerative Colitis

    Abstract

    Objective: There is a large amount of data on fecal microbiome composition in inflammatory bowel disease and ulcerative colitis, but the...

    S. A. Tsvetikova, E. E. Kruglov, ... E. I. Koshel in Russian Journal of Bioorganic Chemistry
    Article 09 April 2024
  2. IL-22 promotes occludin expression by activating autophagy and treats ulcerative colitis

    IL-22 serves a protective function in the intestinal barrier. These protective properties of IL-22 may offer a potential treatment for ulcerative...

    Hui Nong, Haifeng Yuan, ... Yuanneng Chen in Molecular and Cellular Biochemistry
    Article 13 July 2023
  3. Integrative analysis of single-cell RNA-seq and gut microbiome metabarcoding data elucidates macrophage dysfunction in mice with DSS-induced ulcerative colitis

    Ulcerative colitis (UC) is a significant inflammatory bowel disease caused by an abnormal immune response to gut microbes. However, there are still...

    Dawon Hong, Hyo Keun Kim, ... Seokhyun Yoon in Communications Biology
    Article Open access 15 June 2024
  4. Mitochondrial dysfunction promotes microbial composition that negatively impacts on ulcerative colitis development and progression

    Recent evidence demonstrates potential links between mitochondrial dysfunction and inflammatory bowel diseases (IBD). In addition, bidirectional...

    Ainize Peña-Cearra, Deguang Song, ... Leticia Abecia in npj Biofilms and Microbiomes
    Article Open access 07 October 2023
  5. Chitosan functionalized Mn3O4 nanoparticles counteracts ulcerative colitis in mice through modulation of cellular redox state

    Recent findings suggest a key role for reactive oxygen species (ROS) in the pathogenesis and progression of ulcerative colitis (UC). Several studies...

    Susmita Mondal, Monojit Das, ... Samir Kumar Pal in Communications Biology
    Article Open access 16 June 2023
  6. Anti-apoptotic genes and non-coding RNAs are potential outcome predictors for ulcerative colitis

    Due to the lack of clinical, immunologic, genetic, and laboratory markers to predict remission in ulcerative colitis (UC) without relapse, there is...

    Wei Meng, Kay-Martin Johnsen, ... Ruth H. Paulssen in Functional & Integrative Genomics
    Article Open access 18 May 2023
  7. Circadian clock-related genome-wide mendelian randomization identifies putatively genes for ulcerative colitis and its comorbidity

    Background

    Circadian rhythm is crucial to the function of the immune system. Disorders of the circadian rhythm can contribute to inflammatory diseases...

    Mengfen Huang, Yuan Wu, ... Yan Feng in BMC Genomics
    Article Open access 01 February 2024
  8. Identification of ulcerative colitis-specific immune cell signatures from public single-cell RNA-seq data

    Background

    Single-cell RNA-seq enabled microscopic studies on tissue microenvironment of many diseases. Inflammatory bowel disease, an autoimmune...

    Hanbyeol Kim, Hyo Keun Kim, ... Seokhyun Yoon in Genes & Genomics
    Article 03 May 2023
  9. Emu Oil and zinc monoglycerolate independently reduce disease severity in a rat model of ulcerative colitis

    Ulcerative colitis is characterized by colonic inflammation. Previously, Emu Oil protected the intestine against experimentally-induced inflammatory...

    Suzanne Mashtoub, Gordon S Howarth in BioMetals
    Article Open access 05 July 2023
  10. Hinesol attenuates DSS-induced ulcerative colitis through the suppression of Src-mediated NF-κB and chemokine signaling pathway

    As a common inflammatory bowel disease, ulcerative colitis (UC) is featured with inflammation, oxidative damage, and the impairment of intestinal...

    Yun-xia Li, **zhong Liu, Fang Li in Cell Biochemistry and Biophysics
    Article 08 July 2024
  11. Production of recombinant human long-acting IL-18 binding protein: inhibitory effect on ulcerative colitis in mice

    Abstract

    Interleukin-18 binding protein (IL-18BP) is a natural IL-18 inhibitor in vivo , which can effectively neutralize IL-18 and inhibit the...

    Lei Guo, **uze Chen, ... Yechen **ao in Applied Microbiology and Biotechnology
    Article 28 September 2023
  12. The development of probiotics and prebiotics therapy to ulcerative colitis: a therapy that has gained considerable momentum

    Ulcerative colitis (UC) is increasingly common, and it is gradually become a kind of global epidemic. UC is a type of inflammatory bowel disease...

    **g Guo, Li** Li, ... Yongbo Kang in Cell Communication and Signaling
    Article Open access 14 May 2024
  13. Therapeutic effects of genistein in experimentally induced ulcerative colitis in rats via affecting mitochondrial biogenesis

    Ulcerative colitis (UC) is an inflammatory bowel disease that affects the mucosa of the colon, resulting in severe inflammation and ulcers. Genistein...

    Talal S. Alharbi, Ziyad S. Alshammari, ... Mohammed M. H. Al-Gayyar in Molecular and Cellular Biochemistry
    Article 21 April 2023
  14. Protective effect and mechanism insight of purified Antarctic krill phospholipids against mice ulcerative colitis combined with bioinformatics

    Antarctic krill oil is functional oil and has a complex phospholipids composition that poses difficulties in elucidating its effect mechanism on...

    Rong Huang, Jiaxu Yao, ... Jikai Liu in Natural Products and Bioprospecting
    Article Open access 05 April 2023
  15. Diagnosis of Crohn’s disease and ulcerative colitis using the microbiome

    Background

    Inflammatory bowel disease (IBD) is a multifactorial chronic inflammatory disease resulting from dysregulation of the mucosal immune...

    Da-Yeon Kang, Jong-Lyul Park, ... Seon-Young Kim in BMC Microbiology
    Article Open access 11 November 2023
  16. Fecal microbiota transplantation as a therapy for treating ulcerative colitis: an overview of systematic reviews

    Aim

    The current overview on published systematic reviews (SRs) and meta-analysis (MAs) aimed to systematically gather, evaluate, and synthesize solid...

    Haixia Liu, **g Li, ... Youqi Xu in BMC Microbiology
    Article Open access 29 November 2023
  17. Identification of Plant-Based Bio-Actives in the Treatment of Ulcerative Colitis Using Virtual Screening and In Vivo Approaches

    Ulcerative colitis (UC) is a kind of persistent inflammatory bowel disease that is a root cause for lifelong soreness in the colon and rectum...

    Manjunath Dammalli, Bhavya S. Gangadharappa, ... B. E. Rangaswamy in Proceedings of the National Academy of Sciences, India Section B: Biological Sciences
    Article 13 June 2024
  18. Amino acids-targeted metabolomics reveals novel diagnostic biomarkers for ulcerative colitis and Crohn’s disease

    Inflammatory bowel disease (IBD), which mainly comprises ulcerative colitis (UC) and Crohn’s disease (CD), is a common chronic intestinal...

    Guisheng Zhou, Huanhuan Liu, ... Shijia Liu in Amino Acids
    Article 10 January 2023
  19. Altered fecal bile acid composition in active ulcerative colitis

    Background

    Disturbed bile acid homeostasis associated with a rise of primary and a decline of secondary bile acids is a consistent finding in...

    Stefanie Sommersberger, Stefan Gunawan, ... Hauke Christian Tews in Lipids in Health and Disease
    Article Open access 18 November 2023
  20. Single-cell and microarray chip analysis revealed the underlying pathogenesis of ulcerative colitis and validated model genes in diagnosis and drug response

    The morbidity rate of ulcerative colitis (UC) in the world is increasing year by year, recurrent episodes of diarrhea, mucopurulent and bloody...

    Liqing Yang, Haiying Chen, ... Keren Chen in Human Cell
    Article Open access 29 November 2022
Did you find what you were looking for? Share feedback.